Critical Care Explorations最新文献

{"title":"Economic Analysis of Renal Replacement Therapy Modality in Acute Kidney Injury Patients With Fluid Overload.","authors":"Olivier Ethgen,&nbsp;Raghavan Murugan,&nbsp;Jorge Echeverri,&nbsp;Michael Blackowicz,&nbsp;Kai Harenski,&nbsp;Marlies Ostermann","doi":"10.1097/CCE.0000000000000921","DOIUrl":"https://doi.org/10.1097/CCE.0000000000000921","url":null,"abstract":"<p><p>Acute kidney injury (AKI) and fluid overload (FO) are among the top reasons to initiate intermittent hemodialysis (IHD) or continuous renal replacement therapy (CRRT). Prior research suggests CRRT provides more precise volume control, but whether CRRT is cost-effective remains unclear. We assessed the cost-effectiveness of CRRT for volume control compared with IHD from a U.S. healthcare payer perspective.</p><p><strong>Design: </strong>Decision analytical model comparing health outcomes and healthcare costs of CRRT versus IHD initiation for AKI patients with FO. The model had an inpatient phase (over 90-d) followed by post-discharge phase (over lifetime). The 90-day phase had three health states: FO, fluid control, and death. After 90 days, surviving patients entered the lifetime phase with four health states: dialysis independent (DI), dialysis dependent (DD), renal transplantation, and death. Model parameters were informed by current literature. Sensitivity analyses were performed to evaluate results robustness to parametric uncertainty.</p><p><strong>Setting: </strong>ICU.</p><p><strong>Patients or subjects: </strong>AKI patients with FO.</p><p><strong>Interventions: </strong>IHD or CRRT.</p><p><strong>Measurements and main results: </strong>The 90-day horizon revealed better outcomes for patients initiated on CRRT (survival: CRRT 59.2% vs IHD 57.5% and DD rate among survivors: CRRT 5.5% vs IHD 6.9%). Healthcare cost was 2.7% (+$2,836) higher for CRRT. Over lifetime, initial CRRT was associated with +0.313 life years (LYs) and +0.187 quality-adjusted life years (QALYs) compared with initial IHD. Even though important savings were observed for initial CRRT with a lower rate of DD among survivors (-$13,437), it did not fully offset the incremental cost of CRRT (+$1,956) and DI survival (+$12,830). The incremental cost-per-QALY gained with CRRT over IRRT was +$10,429/QALY. Results were robust to sensitivity analyses.</p><p><strong>Conclusions: </strong>Our analysis provides an economic rationale for CRRT as the initial modality of choice in AKI patients with FO who require renal replacement therapy. Our finding needs to be confirmed in future research.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 6","pages":"e0921"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b9/8c/cc9-5-e0921.PMC10456980.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10106867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Preferred Language Mediates Association Between Race, Ethnicity, and Delayed Presentation in Critically Ill Patients With COVID-19.","authors":"Michael S Kelly,&nbsp;Adna Mohammed,&nbsp;Daniel Okin,&nbsp;George A Alba,&nbsp;Sirus J Jesudasen,&nbsp;Shelby Flanagan,&nbsp;Nupur A Dandawate,&nbsp;Alexander Gavralidis,&nbsp;Leslie L Chang,&nbsp;Emily E Moin,&nbsp;Alison S Witkin,&nbsp;Kathryn A Hibbert,&nbsp;Aran Kadar,&nbsp;Patrick L Gordan,&nbsp;Lisa M Bebell,&nbsp;Marissa Hauptman,&nbsp;Linda Valeri,&nbsp;Peggy S Lai","doi":"10.1097/CCE.0000000000000927","DOIUrl":"https://doi.org/10.1097/CCE.0000000000000927","url":null,"abstract":"<p><p>Which social factors explain racial and ethnic disparities in COVID-19 access to care and outcomes remain unclear.</p><p><strong>Objectives: </strong>We hypothesized that preferred language mediates the association between race, ethnicity and delays to care.</p><p><strong>Design setting and participants: </strong>Multicenter, retrospective cohort study of adults with COVID-19 consecutively admitted to the ICU in three Massachusetts hospitals in 2020.</p><p><strong>Main outcome and measures: </strong>Causal mediation analysis was performed to evaluate potential mediators including preferred language, insurance status, and neighborhood characteristics.</p><p><strong>Results: </strong>Non-Hispanic White (NHW) patients (157/442, 36%) were more likely to speak English as their preferred language (78% vs. 13%), were less likely to be un- or under-insured (1% vs. 28%), lived in neighborhoods with lower social vulnerability index (SVI) than patients from racial and ethnic minority groups (SVI percentile 59 [28] vs. 74 [21]) but had more comorbidities (Charlson comorbidity index 4.6 [2.5] vs. 3.0 [2.5]), and were older (70 [13.2] vs. 58 [15.1] years). From symptom onset, NHW patients were admitted 1.67 [0.71-2.63] days earlier than patients from racial and ethnic minority groups (<i>p</i> < 0.01). Non-English preferred language was associated with delay to admission of 1.29 [0.40-2.18] days (<i>p</i> < 0.01). Preferred language mediated 63% of the total effect (<i>p</i> = 0.02) between race, ethnicity and days from symptom onset to hospital admission. Insurance status, social vulnerability, and distance to the hospital were not on the causal pathway between race, ethnicity and delay to admission.</p><p><strong>Conclusions and relevance: </strong>Preferred language mediates the association between race, ethnicity and delays to presentation for critically ill patients with COVID-19, although our results are limited by possible collider stratification bias. Effective COVID-19 treatments require early diagnosis, and delays are associated with increased mortality. Further research on the role preferred language plays in racial and ethnic disparities may identify effective solutions for equitable care.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 6","pages":"e0927"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/14/32/cc9-5-e0927.PMC10270487.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10084913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Thoracic Aortic Injuries Following Intra-Aortic Balloon Pump Placement: A Retrospective Case Series.","authors":"Zachary Kiernan,&nbsp;Kainuo Wu,&nbsp;Abhishek Chaturvedi,&nbsp;Michael C Kontos,&nbsp;Charlotte S Roberts,&nbsp;Keyur Shah,&nbsp;Mohammed Quader","doi":"10.1097/CCE.0000000000000923","DOIUrl":"https://doi.org/10.1097/CCE.0000000000000923","url":null,"abstract":"<p><p>Thoracic aortic injuries from intra-aortic balloon pump (IABP) are rare, and no publications exist in the context of patients awaiting heart transplantation. We present a single-institution case series involving five patients out of 107 who sustained thoracic aortic injuries following IABP placement awaiting heart transplantation. The goal of this study is to describe the characteristics of patients, presenting symptoms, treatment and the impact of these injuries on their suitability for transplantation.</p><p><strong>Design: </strong>Retrospective, single-institution study through chart review of five patients with known thoracic aortic injuries following IABP placement awaiting heart transplant.</p><p><strong>Setting: </strong>Tertiary care academic teaching hospital with all patients requiring cardiac ICU admission.</p><p><strong>Patients: </strong>All five patients were diagnosed with advanced heart failure awaiting heart transplantation.</p><p><strong>Interventions: </strong>Each patient had an IABP placed while awaiting transplant.</p><p><strong>Measurements and main results: </strong>Five patients (4.6%) out of a total of 107 supported with IABP awaiting heart transplantation were identified with thoracic aortic injury. Three underwent transplantation and subsequently received thoracic endovascular aortic repair, and they are doing well with a mean follow-up of 6 months. One patient died acutely and the other did not require intervention.</p><p><strong>Conclusions: </strong>IABP-related aortic injuries may be more common in patients awaiting transplantation and that endovascular therapy is a suitable treatment modality with no immediate impact on transplantation outcomes. Pooled data from multiple centers may help identify patients risk profile to potentially design an algorithm that can more quickly identify these injuries.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 6","pages":"e0923"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c2/ff/cc9-5-e0923.PMC10456978.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10110076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Implementation of a Virtual Interprofessional ICU Learning Collaborative: Successes, Challenges, and Initial Reactions From the Structured Team-Based Optimal Patient-Centered Care for Virus COVID-19 Collaborators.","authors":"Simon Zec,&nbsp;Nika Zorko Garbajs,&nbsp;Yue Dong,&nbsp;Ognjen Gajic,&nbsp;Christina Kordik,&nbsp;Lori Harmon,&nbsp;Marija Bogojevic,&nbsp;Romil Singh,&nbsp;Yuqiang Sun,&nbsp;Vikas Bansal,&nbsp;Linh Vu,&nbsp;Kelly Cawcutt,&nbsp;John M Litell,&nbsp;Sarah Redmond,&nbsp;Eleanor Fitzpatrick,&nbsp;Kirstin J Kooda,&nbsp;Michelle Biehl,&nbsp;Neha S Dangayach,&nbsp;Viren Kaul,&nbsp;June M Chae,&nbsp;Aaron Leppin,&nbsp;Mathew Siuba,&nbsp;Rahul Kashyap,&nbsp;Allan J Walkey,&nbsp;Alexander S Niven","doi":"10.1097/CCE.0000000000000922","DOIUrl":"https://doi.org/10.1097/CCE.0000000000000922","url":null,"abstract":"<p><p>Initial Society of Critical Care Medicine Discovery Viral Infection and Respiratory illness Universal Study (VIRUS) Registry analysis suggested that improvements in critical care processes offered the greatest modifiable opportunity to improve critically ill COVID-19 patient outcomes.</p><p><strong>Objectives: </strong>The Structured Team-based Optimal Patient-Centered Care for Virus COVID-19 ICU Collaborative was created to identify and speed implementation of best evidence based COVID-19 practices.</p><p><strong>Design setting and participants: </strong>This 6-month project included volunteer interprofessional teams from VIRUS Registry sites, who received online training on the Checklist for Early Recognition and Treatment of Acute Illness and iNjury approach, a structured and systematic method for delivering evidence based critical care. Collaborators participated in weekly 1-hour videoconference sessions on high impact topics, monthly quality improvement (QI) coaching sessions, and received extensive additional resources for asynchronous learning.</p><p><strong>Main outcomes and measures: </strong>Outcomes included learner engagement, satisfaction, and number of QI projects initiated by participating teams.</p><p><strong>Results: </strong>Eleven of 13 initial sites participated in the Collaborative from March 2, 2021, to September 29, 2021. A total of 67 learners participated in the Collaborative, including 23 nurses, 22 physicians, 10 pharmacists, nine respiratory therapists, and three nonclinicians. Site attendance among the 11 sites in the 25 videoconference sessions ranged between 82% and 100%, with three sites providing at least one team member for 100% of sessions. The majority reported that topics matched their scope of practice (69%) and would highly recommend the program to colleagues (77%). A total of nine QI projects were initiated across three clinical domains and focused on improving adherence to established critical care practice bundles, reducing nosocomial complications, and strengthening patient- and family-centered care in the ICU. Major factors impacting successful Collaborative engagement included an engaged interprofessional team; an established culture of engagement; opportunities to benchmark performance and accelerate institutional innovation, networking, and acclaim; and ready access to data that could be leveraged for QI purposes.</p><p><strong>Conclusions and relevance: </strong>Use of a virtual platform to establish a learning collaborative to accelerate the identification, dissemination, and implementation of critical care best practices for COVID-19 is feasible. Our experience offers important lessons for future collaborative efforts focused on improving ICU processes of care.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 6","pages":"e0922"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2a/e2/cc9-5-e0922.PMC10456981.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10112161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Epoprostenol Exposure During Pregnancy.","authors":"Emily E Naoum,&nbsp;Carolyn LaVita,&nbsp;Natasha Lopez,&nbsp;Alexa Nardone,&nbsp;Marti D Soffer,&nbsp;Kenneth T Shelton","doi":"10.1097/CCE.0000000000000928","DOIUrl":"https://doi.org/10.1097/CCE.0000000000000928","url":null,"abstract":"<p><p>Institutional policies restricting pregnant providers from caring for patients receiving inhaled epoprostenol exist across the nation based on little to no data to substantiate this practice. Over the last 2 decades, the use of inhaled pulmonary vasodilators has expanded in patients with cardiac and respiratory disease providing more evidence for the safety of these medications in obstetrical patients. We propose a thoughtful consideration and review of the literature to remove this restriction to reduce the need to reveal early pregnancy status to employers, to alleviate undue stress for pregnant caregivers who are exposed to patients receiving epoprostenol, and to ensure safe, equal employment, and learning opportunities for pregnant providers.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 6","pages":"e0928"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/33/af/cc9-5-e0928.PMC10456979.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10112166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Inhaled Prostacyclins for Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis.","authors":"Heather Torbic,&nbsp;Aftabh Saini,&nbsp;Mary Pat Harnegie,&nbsp;Divyajot Sadana,&nbsp;Abhijit Duggal","doi":"10.1097/CCE.0000000000000931","DOIUrl":"https://doi.org/10.1097/CCE.0000000000000931","url":null,"abstract":"<p><p>Studies evaluating inhaled prostacyclins for the management of acute respiratory distress syndrome (ARDS) have produced inconsistent results regarding their effect on oxygenation. The purpose of this systematic review and meta-analysis was to evaluate the change in the Pao₂/Fio₂ ratio after administration of an inhaled prostacyclin in patients with ARDS.</p><p><strong>Data sources: </strong>We searched Ovid Medline, Embase, Cumulative Index to Nursing and Allied Health Literature, Cochrane, Scopus, and Web of Science.</p><p><strong>Study selection: </strong>We included abstracts and trials evaluating administration of inhaled prostacyclins in patients with ARDS.</p><p><strong>Data extraction: </strong>Change in the Pao₂/Fio₂ ratio, Pao₂, and mean pulmonary artery pressure (mPAP) were extracted from included studies. Evidence certainty and risk of bias were evaluated using Grading of Recommendations Assessment, Development, and Evaluation and the Cochrane Risk of Bias tool.</p><p><strong>Data synthesis: </strong>We included 23 studies (1,658 patients) from 6,339 abstracts identified by our search strategy. The use of inhaled prostacyclins improved oxygenation by increasing the Pao₂/Fio₂ ratio from baseline (mean difference [MD], 40.35; 95% CI, 26.14-54.56; <i>p</i> < 0.00001; <i>I</i>² = 95%; very low quality evidence). Of the eight studies to evaluate change in Pao₂, inhaled prostacyclins also increased Pao₂ from baseline (MD, 12.68; 95% CI, 2.89-22.48 mm Hg; <i>p</i> = 0.01; <i>I</i>² = 96%; very low quality evidence). Only three studies evaluated change in mPAP, but inhaled prostacyclins were found to improve mPAP from baseline (MD, -3.67; 95% CI, -5.04 to -2.31 mm Hg; <i>p</i> < 0.00001; <i>I</i>² = 68%; very low quality evidence).</p><p><strong>Conclusions: </strong>In patients with ARDS, use of inhaled prostacyclins improves oxygenation and reduces pulmonary artery pressures. Overall data are limited and there was high risk of bias and heterogeneity among included studies. Future studies evaluating inhaled prostacyclins for ARDS should evaluate their role in ARDS subphenotypes, including cardiopulmonary ARDS.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 6","pages":"e0931"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/94/96/cc9-5-e0931.PMC10256381.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9992417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Muscle Ultrasound Changes and Physical Function of Critically Ill Children: A Comparison of Rectus Femoris Cross-Sectional Area and Quadriceps Thickness Measurements.","authors":"Chengsi Ong,&nbsp;Jan Hau Lee,&nbsp;Melvin K S Leow,&nbsp;Zudin A Puthucheary","doi":"10.1097/CCE.0000000000000937","DOIUrl":"https://doi.org/10.1097/CCE.0000000000000937","url":null,"abstract":"<p><p>Quadriceps thickness (QT) and rectus femoris cross-sectional area (RF_CSA) are both used to evaluate muscle changes in critically ill children. However, their correlation and association with physical function has not been compared.</p><p><strong>Objectives: </strong>To compare QT with RF_CSA changes, and their association with physical function in critically ill children.</p><p><strong>Design setting and participants: </strong>Secondary analysis of a prospective cohort study of children 0-18 years old admitted to a tertiary mixed PICU between January 2015 and October 2018 with PICU stay greater than 48 hours and greater than or equal to one organ dysfunction.</p><p><strong>Main outcomes and measures: </strong>Ultrasound QT and RF_CSA were measured at PICU admission, PICU discharge, hospital discharge, and 6 months post-discharge. QT and RF_CSA changes from baseline were compared with each other and with change in motor function, physical ability, and physical health-related quality of life (HRQOL).</p><p><strong>Results: </strong>Two hundred thirty-seven images from 66 subjects were analyzed. RF_CSA change was not significantly different from QT change at PICU (-8.07% [interquartile range (IQR), -17.11% to 4.80%] vs -4.55% [IQR, -14.32% to 4.35%]; <i>p</i> = 0.927) or hospital discharge (-5.62% [IQR, -15.00% to 9.42%] vs -8.81% [IQR, -18.67% to 2.39%]; <i>p</i> = 0.238) but was significantly greater than QT change at 6 months (32.7% [IQR, 5.74-109.76%] vs 9.66% [IQR, -8.17% to 25.70%]; <i>p</i> < 0.001). Motor function change at PICU discharge was significantly associated with RF_CSA change (adjusted β coefficient, 0.02 [95% CI, 0.01-0.03]; <i>p</i> = 0.013) but not QT change (adjusted β coefficient, -0.01 [95% CI, -0.02 to 0.01]; <i>p</i> = 0.415). Similar results were observed for physical HRQOL changes at hospital discharge (adjusted β coefficient for RF_CSA change, 0.51 [95% CI, 0.10-0.92]; <i>p</i> = 0.017 and adjusted β coefficient for QT change, -0.21 [-0.76 to 0.35]; <i>p</i> = 0.458). Physical ability was not significantly associated with RFCSA or QT changes at 6 months post-discharge.</p><p><strong>Conclusions and relevance: </strong>Ultrasound derived RF_CSA is associated with PICU motor function and hospital discharge physical HRQOL changes, unlike QT, and may be more useful for in-hospital muscle monitoring in critically ill children.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 6","pages":"e0937"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5d/09/cc9-5-e0937.PMC10281326.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9708815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of Transfused Citrate on Pathophysiology in Massive Transfusion.","authors":"Jacob B Schriner, J Michael Van Gent, M Adam Meledeo, Scott D Olson, Bryan A Cotton, Charles S Cox, Brijesh S Gill","doi":"10.1097/CCE.0000000000000925","DOIUrl":"10.1097/CCE.0000000000000925","url":null,"abstract":"<p><p>This narrative review article seeks to highlight the effects of citrate on physiology during massive transfusion of the bleeding patient.</p><p><strong>Data sources: </strong>A limited library of curated articles was created using search terms including \"citrate intoxication,\" \"citrate massive transfusion,\" \"citrate pharmacokinetics,\" \"hypocalcemia of trauma,\" \"citrate phosphate dextrose,\" and \"hypocalcemia in massive transfusion.\" Review articles, as well as prospective and retrospective studies were selected based on their relevance for inclusion in this review.</p><p><strong>Study selection: </strong>Given the limited number of relevant studies, studies were reviewed and included if they were written in English. This is not a systematic review nor a meta-analysis.</p><p><strong>Data extraction and synthesis: </strong>As this is not a meta-analysis, new statistical analyses were not performed. Relevant data were summarized in the body of the text.</p><p><strong>Conclusions: </strong>The physiologic effects of citrate independent of hypocalcemia are poorly understood. While a healthy individual can rapidly clear the citrate in a unit of blood (either through the citric acid cycle or direct excretion in urine), the physiology of hemorrhagic shock can lead to decreased clearance and prolonged circulation of citrate. The so-called \"Diamond of Death\" of bleeding-coagulopathy, acidemia, hypothermia, and hypocalcemia-has a dynamic interaction with citrate that can lead to a death spiral. Hypothermia and acidemia both decrease citrate clearance while circulating citrate decreases thrombin generation and platelet function, leading to ionized hypocalcemia, coagulopathy, and need for further transfusion resulting in a new citrate load. Whole blood transfusion typically requires lower volumes of transfused product than component therapy alone, resulting in a lower citrate burden. Efforts should be made to limit the amount of citrate infused into a patient in hemorrhagic shock while simultaneously addressing the induced hypocalcemia.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 6","pages":"e0925"},"PeriodicalIF":0.0,"publicationDate":"2023-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c6/b7/cc9-5-e0925.PMC10234463.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10058219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pediatric Swine Model of Methicillin-Resistant <i>Staphylococcus aureus</i> Sepsis-Induced Coagulopathy, Disseminated Microvascular Thrombosis, and Organ Injuries.","authors":"Trung C Nguyen, Juan C Marini, Bobby Guillory, Christian Valladolid-Brown, Marina Martinez-Vargas, Deepika Subramanyam, Daniel Cohen, Sonya C Cirlos, Fong Lam, Barbara Stoll, Inka C Didelija, Caitlin Vonderohe, Renan Orellana, Arun Saini, Subhashree Pradhan, Dalia Bashir, Moreshwar S Desai, Saul Flores, Manpreet Virk, Hossein Tcharmtchi, Amir Navaei, Sheldon Kaplan, Linda Lamberth, Kristina G Hulten, Brooks P Scull, Carl E Allen, Ayse Akcan-Arikan, K Vinod Vijayan, Miguel A Cruz","doi":"10.1097/CCE.0000000000000916","DOIUrl":"10.1097/CCE.0000000000000916","url":null,"abstract":"<p><p>Sepsis-induced coagulopathy leading to disseminated microvascular thrombosis is associated with high mortality and has no existing therapy. Despite the high prevalence of Gram-positive bacterial sepsis, especially methicillin-resistant <i>Staphylococcus aureus</i> (MRSA), there is a paucity of published Gram-positive pediatric sepsis models. Large animal models replicating sepsis-induced coagulopathy are needed to test new therapeutics before human clinical trials.</p><p><strong>Hypothesis: </strong>Our objective is to develop a pediatric sepsis-induced coagulopathy swine model that last 70 hours.</p><p><strong>Methods and models: </strong>Ten 3 weeks old piglets, implanted with telemetry devices for continuous hemodynamic monitoring, were IV injected with MRSA (<i>n</i> = 6) (USA300, Texas Children's Hospital 1516 strain) at 1 × 10⁹ colony forming units/kg or saline (<i>n</i> = 4). Fluid resuscitation was given for heart rate greater than 50% or mean arterial blood pressure less than 30% from baseline. Acetaminophen and dextrose were provided as indicated. Point-of-care complete blood count, prothrombin time (PT), activated thromboplastin time, d-dimer, fibrinogen, and specialized coagulation assays were performed at pre- and post-injection, at 0, 24, 48, 60, and 70 hours. Piglets were euthanized and necropsies performed.</p><p><strong>Results: </strong>Compared with the saline treated piglets (control), the septic piglets within 24 hours had significantly lower neurologic and respiratory scores. Over time, PT, d-dimer, and fibrinogen increased, while platelet counts and activities of factors V, VII, protein C, antithrombin, and a disintegrin and metalloproteinase with thrombospondin-1 motifs (13th member of the family) (ADAMTS-13) decreased significantly in septic piglets compared with control. Histopathologic examination showed minor focal organ injuries including microvascular thrombi and necrosis in the kidney and liver of septic piglets.</p><p><strong>Interpretations and conclusions: </strong>We established a 70-hour swine model of MRSA sepsis-induced coagulopathy with signs of consumptive coagulopathy, disseminated microvascular thrombosis, and early organ injuries with histological minor focal organ injuries. This model is clinically relevant to pediatric sepsis and can be used to study dysregulated host immune response and coagulopathy to infection, identify potential early biomarkers, and to test new therapeutics.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 6","pages":"e0916"},"PeriodicalIF":0.0,"publicationDate":"2023-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f0/2f/cc9-5-e0916.PMC10226618.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9696550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparator Groups in ICU-Based Studies of Physical Rehabilitation: A Scoping Review of 125 Studies.","authors":"Heather K O'Grady, Julie C Reid, Christopher Farley, Quincy E B Hanna, Janelle Unger, David J Zorko, Jackie Bosch, Lyn S Turkstra, Michelle E Kho","doi":"10.1097/CCE.0000000000000917","DOIUrl":"10.1097/CCE.0000000000000917","url":null,"abstract":"<p><p>To characterize comparator groups (CGs) in ICU-based studies of physical rehabilitation (PR), including the type, content, and reporting.</p><p><strong>Data sources: </strong>We followed a five-stage scoping review methodology, searching five databases from inception to June 30, 2022. Study selection and data extraction were completed independently, in duplicate.</p><p><strong>Study selection: </strong>We screened studies by title and abstract, then full-text. We included prospective studies with greater than or equal to two arms enrolling mechanically ventilated adults (≥ 18 yr), with any planned PR intervention initiated in the ICU.</p><p><strong>Data extraction: </strong>We conducted a quantitative content analysis of authors' description of CG type and content. We categorized similar CG types (e.g., usual care), classified content into unique activities (e.g., positioning), and summarized these data using counts (proportions). We assessed reporting using Consensus on Exercise Reporting Template (CERT; proportion of reported items/total applicable).</p><p><strong>Data synthesis: </strong>One hundred twenty-five studies were included, representing 127 CGs. PR was planned in 112 CGs (88.2%; 110 studies), representing four types: usual care (<i>n</i> = 81, 63.8%), alternative treatment than usual care (e.g., different from intervention; <i>n</i> = 18, 14.2%), alternative treatment plus usual care (<i>n</i> = 7, 5.5%), and sham (<i>n</i> = 6, 4.7%). Of 112 CGs with planned PR, 90 CGs (88 studies) reported 60 unique activities, most commonly passive range of motion (<i>n</i> = 47, 52.2%). The remaining 22 CGs (19.6%; 22 studies) reported vague descriptions. PR was not planned in 12 CGs (9.5%; 12 studies), and three CGs (2.4%; three studies) reported no details. Studies reported a median (Q1-Q3) of 46.6% (25.0-73.3%) CERT items. Overall, 20.0% of studies reported no detail to understand planned CG activities.</p><p><strong>Conclusions: </strong>The most common type of CG was usual care. We identified heterogeneity in planned activities and CERT reporting deficiencies. Our results could help guide the selection, design, and reporting of CGs in future ICU-based PR studies.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 5","pages":"e0917"},"PeriodicalIF":0.0,"publicationDate":"2023-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f9/b2/cc9-5-e0917.PMC10171473.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9470407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}